207 related articles for article (PubMed ID: 34111979)
1. Cannabinoid receptor type 2 ligands: an analysis of granted patents since 2010.
Brennecke B; Gazzi T; Atz K; Fingerle J; Kuner P; Schindler T; Weck G; Nazaré M; Grether U
Pharm Pat Anal; 2021 May; 10(3):111-163. PubMed ID: 34111979
[TBL] [Abstract][Full Text] [Related]
2. N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R).
Graziano G; Delre P; Carofiglio F; Brea J; Ligresti A; Kostrzewa M; Riganti C; Gioè-Gallo C; Majellaro M; Nicolotti O; Colabufo NA; Abate C; Loza MI; Sotelo E; Mangiatordi GF; Contino M; Stefanachi A; Leonetti F
Eur J Med Chem; 2023 Feb; 248():115109. PubMed ID: 36657299
[TBL] [Abstract][Full Text] [Related]
3. Patent review of cannabinoid receptor type 2 (CB
Kosar M; Mach L; Carreira EM; Nazaré M; Pacher P; Grether U
Expert Opin Ther Pat; 2024 Jun; ():. PubMed ID: 38886185
[TBL] [Abstract][Full Text] [Related]
4. Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.
Porter RF; Szczesniak AM; Toguri JT; Gebremeskel S; Johnston B; Lehmann C; Fingerle J; Rothenhäusler B; Perret C; Rogers-Evans M; Kimbara A; Nettekoven M; Guba W; Grether U; Ullmer C; Kelly MEM
Molecules; 2019 Sep; 24(18):. PubMed ID: 31540271
[TBL] [Abstract][Full Text] [Related]
5. Receptor-dependent and receptor-independent endocannabinoid signaling: a therapeutic target for regulation of cancer growth.
Van Dross R; Soliman E; Jha S; Johnson T; Mukhopadhyay S
Life Sci; 2013 Mar; 92(8-9):463-6. PubMed ID: 23069587
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons.
Stumpf A; Parthier D; Sammons RP; Stempel AV; Breustedt J; Rost BR; Schmitz D
Neuropharmacology; 2018 Sep; 139():217-225. PubMed ID: 30025920
[TBL] [Abstract][Full Text] [Related]
7. Patents targeting cannabinoid receptor type 2 ligands: an interview with Uwe Grether.
Grether U
Pharm Pat Anal; 2021 Jul; 10(4):175-177. PubMed ID: 34365800
[No Abstract] [Full Text] [Related]
8. Cannabinoid Receptors and Ligands: Lessons from CNS Disorders and the Quest for Novel Treatment Venues.
Vecchini Rodríguez CM; Escalona Meléndez Y; Flores-Otero J
Adv Exp Med Biol; 2021; 1297():43-64. PubMed ID: 33537936
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid Receptors in Diabetic Kidney Disease.
Barutta F; Mastrocola R; Bellini S; Bruno G; Gruden G
Curr Diab Rep; 2018 Feb; 18(2):9. PubMed ID: 29399721
[TBL] [Abstract][Full Text] [Related]
10. Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB
Ferrisi R; Ceni C; Bertini S; Macchia M; Manera C; Gado F
Pharmacol Res; 2021 Aug; 170():105607. PubMed ID: 34089867
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid type-2 receptor agonist, inverse agonist, and anandamide regulation of inflammatory responses in IL-1β stimulated primary human periodontal ligament fibroblasts.
Abidi AH; Alghamdi SS; Dabbous MK; Tipton DA; Mustafa SM; Moore BM
J Periodontal Res; 2020 Oct; 55(5):762-783. PubMed ID: 32562275
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptors and their ligands.
Pertwee RG; Ross RA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts.
Abidi AH; Presley CS; Dabbous M; Tipton DA; Mustafa SM; Moore BM
Arch Oral Biol; 2018 Mar; 87():79-85. PubMed ID: 29274621
[TBL] [Abstract][Full Text] [Related]
14. Is GPR55 an anandamide receptor?
Brown AJ; Robin Hiley C
Vitam Horm; 2009; 81():111-37. PubMed ID: 19647110
[TBL] [Abstract][Full Text] [Related]
15. Bridging the Binding Sites 2.0: Photoswitchable Dualsteric Ligands for the Cannabinoid 2 Receptor.
Steinmüller SAM; Tutov A; Hislop JN; Decker M
ACS Chem Neurosci; 2023 Oct; 14(20):3737-3744. PubMed ID: 37792463
[TBL] [Abstract][Full Text] [Related]
16. Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor.
Chiurchiù V; Lanuti M; Catanzaro G; Fezza F; Rapino C; Maccarrone M
Atherosclerosis; 2014 Mar; 233(1):55-63. PubMed ID: 24529123
[TBL] [Abstract][Full Text] [Related]
17. Structural and Functional Insights into Cannabinoid Receptors.
Li X; Shen L; Hua T; Liu ZJ
Trends Pharmacol Sci; 2020 Sep; 41(9):665-677. PubMed ID: 32739033
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.
Pacher P; Steffens S; Haskó G; Schindler TH; Kunos G
Nat Rev Cardiol; 2018 Mar; 15(3):151-166. PubMed ID: 28905873
[TBL] [Abstract][Full Text] [Related]
19. The progress of small molecules against cannabinoid 2 receptor (CB
Zhang Q; Zhao Y; Wu J; Zhong W; Huang W; Pan Y
Bioorg Chem; 2024 Mar; 144():107075. PubMed ID: 38218067
[TBL] [Abstract][Full Text] [Related]
20. Two Affinity Sites of the Cannabinoid Subtype 2 Receptor Identified by a Novel Homogeneous Binding Assay.
Martínez-Pinilla E; Rabal O; Reyes-Resina I; Zamarbide M; Navarro G; Sánchez-Arias JA; de Miguel I; Lanciego JL; Oyarzabal J; Franco R
J Pharmacol Exp Ther; 2016 Sep; 358(3):580-7. PubMed ID: 27358483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
